NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
Ultrasound-Activated Drug Delivery: Precision Medicine Through Molecular Control
TL;DR
Ultrasound-controlled drug activation gives pharmaceutical companies a competitive edge by enabling targeted therapies that minimize side effects and improve treatment efficacy.
Ultrasound triggers mechanical forces and reactive oxygen species to selectively cleave chemical bonds within polymer carriers for precise drug release control.
This technology makes the world better by enabling safer, more precise medical treatments that reduce systemic toxicity and improve patient outcomes.
Researchers use ultrasound to activate drugs only where needed, like molecular switches triggered by sound waves for targeted cancer therapy.
Found this article helpful?
Share it with your network and spread the knowledge!
Ultrasound-activated drug delivery uses ultrasound-generated mechanical forces to selectively cleave covalent and non-covalent bonds in polymer-based drug carriers, triggering on-demand drug release at the molecular level with high spatial and temporal precision.
Ultrasound provides a tunable, non-invasive physical trigger that penetrates deep tissues without damaging surrounding cells, unlike light, heat, or magnetic fields which have limitations including limited penetration, high invasiveness, or biological incompatibility.
This approach allows targeted activation of therapeutic agents only at desired sites, minimizing side effects, improving drug efficacy, and reducing systemic exposure and toxicity compared to conventional drug delivery methods.
The three pathways are: covalent bond cleavage systems (like disulfide-based mechanisms), non-covalent disruption systems (using supramolecular cages and weaker intermolecular forces), and nanomaterial-based ROS activation systems that generate reactive oxygen species for controlled drug release.
Researchers from Tianjin University published a comprehensive review on ultrasound-induced drug activation systems in the Chinese Journal of Polymer Science (DOI: 10.1007/s10118-025-3398-3).
Emerging platforms include rotaxane molecular actuators, polymer microbubbles, and high-intensity focused ultrasound (HIFU)-responsive hydrogels, which offer promising strategies for increasing payload capacity and minimizing off-target activation.
Further optimization is needed to improve drug-loading efficiency, enhance biocompatibility, ensure clinical safety, and develop more efficient and safe clinical drug activation platforms.
Unlike conventional methods that rely on passive diffusion or chemical triggers leading to systemic exposure and toxicity, ultrasound-activated systems provide precise, controllable release only when and where needed, significantly improving therapeutic performance.
The comprehensive review is published in the Chinese Journal of Polymer Science with DOI: 10.1007/s10118-025-3398-3, published online in 2025.
Curated from 24-7 Press Release
